Trademark Alertz ®
Search
Trademark
Owner
Trademark: ARVIDAL 2165944
Word
ARVIDAL
ID
2165944
Trademark Type
Fancy, Figurative
Status
Protected: Registered/protected
Application Date
11 December 2020
Registration Date
11 December 2020
Renewal Date
11 December 2030
Owner(s)
PVP LABS PTE. LTD.
Service
Goods and Services:
Class 5
:
Pharmaceutical preparations
;
pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses
;
pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses, namely by intravenous, intramuscular, oral, sublingual, buccal, nasal, topical administration and/or administered by inhalation, by spraying or by nebulisation in patients
;
pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viruses, seasonal and pandemic influenza A and B viruses, seasonal coronaviruses (Alpha-, Beta-, Gamma- and Deltacoronaviruses), severe acute respiratory syndrome (SARS-CoV) coronaviruses and Middle East respiratory syndrome (MERS) coronavirus, adenoviruses, respiratory syncytial viruses, parainfluenza viruses, rhinoviruses, human metapneumoviruses, bocaviruses, and infections of combined etiology (multiple viral infections)
;
pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viral infections of the upper and lower respiratory tract
;
pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of acute respiratory infections caused by viral infections of the upper and lower respiratory tract
;
pharmaceutical preparations and pharmaceutical products for the prevention and treatment of tissue lesions in the lungs caused by severe pulmonary infectious diseases
;
pharmaceutical preparations and pharmaceutical products for the prevention and treatment of complications arising from or caused by viral infections
;
pharmaceutical preparations and pharmaceutical products for the prevention and treatment of acute respiratory infections, acute respiratory viral infections of unknown origins and complications arising from or caused by viral infections.